
Many people at high risk for HIV can't afford PrEP, though it's more than 90 percent effective. The HIV medicine's list price, close to $2,000 for a 30-day supply, has risen 45 percent in six years.
(Image credit: Paul Sakuma/AP)

Many people at high risk for HIV can't afford PrEP, though it's more than 90 percent effective. The HIV medicine's list price, close to $2,000 for a 30-day supply, has risen 45 percent in six years.
(Image credit: Paul Sakuma/AP)